Patents by Inventor Wesley L. Shoop

Wesley L. Shoop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040069235
    Abstract: The present invention is directed to a flea feeding apparatus and method for obtaining in vivo feeding data for fleas feeding from a blood source. In particular, the present invention is directed to a flea feeding apparatus and method for obtaining in vivo flea feeding data for fleas feeding from blood sources such as, for example, a mammal or reptile. The flea feeding apparatus includes a containment system comprised of a subject-restraining apparatus and a removable housing that confine the fleas in proximity with the blood source in order to obtain in vivo flea feeding data. This invention allows a known quantity of fleas to feed on a test blood source undisturbed, followed by the recovery of all of the fleas for further observation and analysis, with minimal stress and manipulation of the blood source (test animal host).
    Type: Application
    Filed: September 29, 2003
    Publication date: April 15, 2004
    Inventors: Cordelia G. Rasa, Harold W. Heimbach, Wesley L. Shoop, Michelle Zakson-Aiken
  • Patent number: 5578581
    Abstract: An active avermectin analogue which can be produced by directed biosynthesis is described. The compound, named 26-R-Avermectin B.sub.
    Type: Grant
    Filed: April 26, 1994
    Date of Patent: November 26, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Prakash S. Masurekar, Wesley L. Shoop, Michael A. Wallace, Richard L. Monaghan
  • Patent number: 5139948
    Abstract: A novel strain of Trichostrongylus colubriformis has the unique characteristics of being significantly resistant to the effect of antihelmintic drugs, in particular the antihelmintic drugs ivermectin and thiabendazole. The novel strain of T. colubriformis was prepared by the serial passage of the helminth through sheep. Twenty passages of the helminth through sheep were adequate to impart resistance to oral therapy of 20 times that normally expected with ivermectin. The highly resistant parasite is useful to screen for antihelmintic agents with different modes of action than that of ivermectin or thiabendazole which represent two of the three major classes of modern, broad spectrum anthelmintics.
    Type: Grant
    Filed: April 9, 1990
    Date of Patent: August 18, 1992
    Assignee: Merck & Co., Inc.
    Inventors: Wesley L. Shoop, John R. Egerton